Senate Extends Pharma Grants Probe

“Receiving a letter from the United States Senate Finance Committee is a frightening experience,” said a CME professional from a major pharmaceutical company during a hot-topics session at the Alliance for CME annual conference. From the comments other attendees made, it appears that many CME professionals, whether on the industry or provider side, agree that the government's focus on funding is definitely something to worry about.